Although the association between GM and BRAF/MEKi has not been described, it is an interesting field of research that needs to be unfolded, considering that it represents one of the main therapies in melanoma patients and that it may help us have a better understanding of molecular pathways, the immune system and microbiome. The gene discussed is BRAF; the disease is melanoma.